126 related articles for article (PubMed ID: 2496463)
21. Conceptual issues in assessing the economic effects of the HIV epidemic.
Pascal A
Health Policy; 1989; 11(2):105-13. PubMed ID: 10303496
[TBL] [Abstract][Full Text] [Related]
22. Estimates of the direct and indirect costs of acquired immunodeficiency syndrome in the United States, 1985, 1986, and 1991.
Scitovsky AA; Rice DP
Public Health Rep; 1987; 102(1):5-17. PubMed ID: 3101123
[TBL] [Abstract][Full Text] [Related]
23. The acquired immune deficiency syndrome and epidemic of infection with human immunodeficiency virus: costs of care and prevention in an inner London district.
Johnson AM; Adler MW; Crown JM
Br Med J (Clin Res Ed); 1986 Aug; 293(6545):489-92. PubMed ID: 3091176
[TBL] [Abstract][Full Text] [Related]
24. Changing use of hospital services and costs at a London AIDS referral centre, 1983-1989.
Beck EJ; Kennelly J; McKevitt C; Whitaker L; Wadsworth J; Miller DL; Easmon C; Pinching AJ; Harris JR
AIDS; 1994 Mar; 8(3):367-77. PubMed ID: 8031516
[TBL] [Abstract][Full Text] [Related]
25. Economic impact of introducing propentofylline for the treatment of dementia in Sweden.
Wimo A; Witthaus E; Rother M; Winblad B
Clin Ther; 1998; 20(3):552-66; discussion 550-1. PubMed ID: 9663370
[TBL] [Abstract][Full Text] [Related]
26. The $147,000 misunderstanding: repercussions of overestimating the cost of AIDS.
Green J; Oppenheimer GM; Wintfeld N
J Health Polit Policy Law; 1994; 19(1):69-90. PubMed ID: 8014423
[TBL] [Abstract][Full Text] [Related]
27. AIDS--fighting the economic epidemic.
Long DL
Nurs Manage; 1987 Sep; 18(9):66-71. PubMed ID: 3114690
[No Abstract] [Full Text] [Related]
28. Preliminary cost-effectiveness analysis of an AIDS vaccine in Abidjan, Ivory Coast.
Cowley P
Health Policy; 1993 May; 24(2):145-53. PubMed ID: 10128800
[TBL] [Abstract][Full Text] [Related]
29. The mounting medical care cost for adult AIDS patients at the Faculty of Medicine, Siriraj Hospital: consideration for management.
Suwanagool S; Ratanasuwan W; Techasathit W
J Med Assoc Thai; 1997 Jul; 80(7):431-9. PubMed ID: 9277072
[TBL] [Abstract][Full Text] [Related]
30. Trends in healthcare expenditure among people living with HIV/AIDS in the United States: evidence from 10 Years of nationally representative data.
Ritchwood TD; Bishu KG; Egede LE
Int J Equity Health; 2017 Oct; 16(1):188. PubMed ID: 29078785
[TBL] [Abstract][Full Text] [Related]
31. Economic consequences of HIV/AIDS in India.
Pandav CS; Anand K; Shamanna BR; Chowdhury S; Nath LM
Natl Med J India; 1997; 10(1):27-30. PubMed ID: 9069706
[TBL] [Abstract][Full Text] [Related]
32. Economic consequences for Medicaid of human immunodeficiency virus infection.
Baily MA; Bilheimer L; Wooldridge J; Langwell K; Greenberg W
Health Care Financ Rev; 1990 Dec; Spec No(Suppl):97-108. PubMed ID: 10113503
[TBL] [Abstract][Full Text] [Related]
33. AIDS: costs of care in the developed and the developing world.
Scitovsky AA; Over M
AIDS; 1988; 2 Suppl 1():S71-81. PubMed ID: 3147683
[TBL] [Abstract][Full Text] [Related]
34. Economic perspectives on the global AIDS epidemic.
Bloom DE
AIDS Patient Care STDS; 1999 Apr; 13(4):229-34. PubMed ID: 10351891
[No Abstract] [Full Text] [Related]
35. Forecasting the personal medical care costs of AIDS from 1988 through 1991.
Hellinger FJ
Public Health Rep; 1988; 103(3):309-19. PubMed ID: 2836880
[TBL] [Abstract][Full Text] [Related]
36. Costs of alien invasive species in Sweden.
Gren IM; Isacs L; Carlsson M
Ambio; 2009 May; 38(3):135-40. PubMed ID: 19580030
[TBL] [Abstract][Full Text] [Related]
37. HIV screening of surgeons and dentists: a cost-effectiveness analysis.
Sell RL; Jovell AJ; Siegel JE
Infect Control Hosp Epidemiol; 1994 Oct; 15(10):635-45. PubMed ID: 7844334
[TBL] [Abstract][Full Text] [Related]
38. Costs of coronary heart disease and stroke: the case of Sweden.
Zethraeus N; Molin T; Henriksson P; Jönsson B
J Intern Med; 1999 Aug; 246(2):151-9. PubMed ID: 10447784
[TBL] [Abstract][Full Text] [Related]
39. Drug and treatment costs in Parkinson's disease patients in Sweden.
Lökk J; Borg S; Svensson J; Persson U; Ljunggren G
Acta Neurol Scand; 2012 Feb; 125(2):142-7. PubMed ID: 21470194
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago.
Immergluck LC; Cull WL; Schwartz A; Elstein AS
Pediatrics; 2000 Apr; 105(4):E54. PubMed ID: 10742375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
